Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Arlidin
2. Bufenine
3. Buphenin
4. Buphenine
5. Dilatol
6. Hydrochloride, Nylidrin
7. Nylidrin
1. 849-55-8
2. Buphenine Hydrochloride
3. Nylidrin (hydrochloride)
4. Nylidrin Hcl
5. Arlibide
6. Arlidin
7. Buphedrin
8. Dilatol
9. Vasiten
10. Buphenin Hydrochloride
11. Nsc-142004
12. Mls000069387
13. Dilatyl
14. Suprifen Psb Hydrochloride
15. 4-[1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl]phenol;hydrochloride
16. Smr000058488
17. Nylidrin Hydrochloride (jan)
18. Ec69e3pw7e
19. Nylidrin Hydrochloride [jan]
20. Sr-01000002981
21. Buphenine Hcl
22. P-hydroxy-.alpha.-[1-[(1-methyl-3-phenylpropyl)amino]ethyl]benzyl Alcohol Hydrochloride
23. P-hydroxy-.alpha.-(1-((1-methyl-3-phenylpropyl)amino)ethyl)benzyl Alcohol Hydrochloride
24. Arlidin (tn)
25. Nylidrine Hydrochloride
26. Opera_id_1722
27. Mls001076116
28. Schembl364078
29. Spectrum1500445
30. Chembl1204337
31. Chebi:31925
32. Dtxsid20957360
33. Hms1920d06
34. Pharmakon1600-01500445
35. Nylidrin Hydrochloride [mi]
36. Amy23363
37. Hy-b1404
38. Tox21_500911
39. Ccg-40183
40. Mfcd00035085
41. Nsc142004
42. Nsc757252
43. S5267
44. Nylidrin Hydrochloride [vandf]
45. Wln: Qr Dyqy1&my1&2r &gh
46. Akos030242878
47. Buphenine Hydrochloride [mart.]
48. Cs-4980
49. Lp00911
50. Nsc-757252
51. Buphenine Hydrochloride [who-dd]
52. Ncgc00094222-01
53. Ncgc00094222-02
54. Ncgc00094222-03
55. Ncgc00094222-04
56. Ncgc00261596-01
57. As-19644
58. Eu-0100911
59. Ft-0757340
60. N-153
61. D01543
62. A923155
63. Q9668243
64. Sr-01000002981-2
65. 4-(1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl)phenol Hydrochloride
66. 1-p-hydroxyphenyl-2-[(1'-methyl-3'-phenylpropyl)amino]-1-propanol Hydrochloride
67. 4-{1-hydroxy-2-[(4-phenyl-2-butanyl)amino]propyl}phenol Hydrochloride (1:1)
68. 900-01-6
69. Benzenemethanol, 4-hydroxy-.alpha.-(1-((1-methyl-3-phenylpropyl)amino)ethyl)-, Hydrochloride
Molecular Weight | 335.9 g/mol |
---|---|
Molecular Formula | C19H26ClNO2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 7 |
Exact Mass | 335.1652068 g/mol |
Monoisotopic Mass | 335.1652068 g/mol |
Topological Polar Surface Area | 52.5 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 296 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 3 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Adrenergic beta-Agonists
Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)
Tocolytic Agents
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?